Event Type: The management of Biocon Limited is scheduled to meet with Analyst(s)/Institutional Investor(s) at two separate conferences. The interactions are specified as '1x1/Group/In-Person'.
Event Schedule:
Date: November 17, 2026
Event: JM Financial Annual India Conference
Venue: Mumbai
Date: November 18, 2026
Event: Avendus Spark Investor Conference
Venue: Mumbai
Regulatory Context: The intimation is made pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Compliance Note: The company explicitly states that it will not disclose any Unpublished Price Sensitive Information (UPSI) during these meetings.
Management Participants: The document does not specify any management participants or their designations.
Presentation/Availability: The document does not indicate if a presentation, earnings deck, transcript, or recording will be made available. It states that the information is available on the company website at www.biocon.com.
Financial Data: No financial highlights, guidance references, or presentation summaries were included in this specific disclosure.
Additional Notes Section
The document is a formal letter addressed to the Secretaries of BSE Limited and the National Stock Exchange of India Limited.
The schedule is noted as being subject to change due to exigencies on the part of Investors or the Company.
The letter is signed by Rajesh U. Shanoy, Company Secretary and Compliance officer (ICSI Membership Number: A16328).
No financial data or operational updates were disclosed in this announcement; it is purely a schedule intimation.
No attachments were mentioned in the provided data text.
